More than 500 new COVID-19 related clinical trials have been registered as of the end of April. The race to find a COVID-19 vaccine is on and the public spotlight is on clinical trials. Strangely named drugs such as Hydroxychloroquine and Remdesivir have become household names and are featured and debated regularly on the 24-hour news channels.
The pressure to find a cure is intense. The locked-down world does not want to hear that at best, we may find a vaccine sometime in 2021. What
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know:
- Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
- Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine.
Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
Net Health Acquires Wound Care Platform Tissue Analytics
What You Should Know:
- Net Health acquires wound care platform Tissue Analytics to expand Net Health’s leadership position in the wound care market.
- Tissue Analytics, Inc. deploys its wound management software via industry-leading SMART on FHIR integrations with Epic, Cerner, Allscripts, and others.
- Net Health plans to integrate Tissue Analytics app will be integrated with their WoundExpert EHR solution to add key capabilities for use within hospital outpatient
Read More
Medable Lands $25M to Expand Platform for Decentralized Clinical Trials
What You Should Know:
- Medable raises $25M in funding to expand global platform for decentralized clinical trials led by GSR Ventures, with additional investment from existing investor PPD, Inc.
- Founded in 2015, Medable’s global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution.
Medable, Inc., a Palo
Alto, CA-based global platform for
Read More
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment.
AiCure,
Read More
Healthcare Data Platform H1 Raises $12.9M to Fuel Growth
What You Should Know:
- H1, the biggest database in the world connecting healthcare, life science professionals, and companies raises $12.9M in funding.
- Its healthcare data platform provides comprehensive in-depth profiles of more than 8 million healthcare professionals and 16,000 institutions in 70+ countries, all of which are kept up-to-date weekly. The platform enables users to understand and analyze any healthcare professional’s full profile, including expertise, interests,
Read More
Central, Searchable Repository for all COVID-19 Clinical Trials Launches
What You Need to Know:
- Inato unveils central, searchable repository for all COVID-19 clinical trials designed to support clinical researchers, physicians, and biopharma organizations.
- By centralizing all clinical studies being conducted worldwide and updating trial trends with new information from public registries and aggregators daily, Inato seeks to optimize COVID-19 clinical trial resource allocation and help address any unmet needs as quickly as possible.
Paris-based (and
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
Chilmark Research: The Promise of AI & ML in Healthcare Report
What You Need to Know:
- New Chilmark Research report reveals artificial intelligence and machine learning (AI/ML) technologies are capturing the imagination of investors and healthcare organizations—and are poised to expand healthcare frontiers.
- The latest report evaluates over 120 commercial AI/ML solutions in healthcare, explores future opportunities, and assesses obstacles to adoption at scale.
Interest and investment in healthcare AI/ML tools
is booming with approximately
Read More
TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?
On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market:
- The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio.
- TeraRecon is an Advanced
Read More
